Free Trial
ASX:RNO

Rhinomed (RNO) Stock Price, News & Analysis

About Rhinomed Stock (ASX:RNO)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
452,773 shs
Average Volume
N/A
Market Capitalization
A$11.47 million
P/E Ratio
N/A
Dividend Yield
3.01%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive RNO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Rhinomed and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

RNO Stock News Headlines

Insider Buyers Lose AU$435k As Rhinomed Sheds AU$1.4m
REVEALED: Something Big Happening Behind White House Doors
what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for yourself. Once you see what’s unfolding behind the scenes, you’ll understand why I rushed this interview and opportunity to you today.tc pixel
Meredith George Bought 6.7% More Shares In Rhinomed \
See More Headlines

RNO Stock Analysis - Frequently Asked Questions

Rhinomed Limited (ASX:RNO) released its quarterly earnings data on Thursday, February, 28th. The company reported ($0.02) earnings per share for the quarter. Rhinomed had a negative net margin of 145.98% and a positive trailing twelve-month return on equity of 1,591.14%.

Based on aggregate information from My MarketBeat watchlists, some other companies that Rhinomed investors own include Pfizer (PFE), NVIDIA (NVDA), PayPal (PYPL), Advanced Micro Devices (AMD), Lowe's Companies (LOW), Energy Vault (NRGV) and Medicine Man Technologies (SHWZ).

Company Calendar

Last Earnings
2/28/2019
Today
9/15/2025

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Medical Devices
Sub-Industry
N/A
Current Symbol
ASX:RNO
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A($0.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-A$10.91 million
Net Margins
-145.98%
Pretax Margin
N/A
Return on Equity
1,591.14%
Return on Assets
-101.64%

Debt

Debt-to-Equity Ratio
-93.28
Current Ratio
0.27
Quick Ratio
1.28

Sales & Book Value

Annual Sales
A$8.05 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
3.48
Book Value
A($0.02) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
286,780,000
Free Float
N/A
Market Cap
A$11.47 million
Optionable
Not Optionable
Beta
0.88
Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (ASX:RNO) was last updated on 9/16/2025 by MarketBeat.com Staff
From Our Partners